Aldosterone-Producing Adrenal Adenoma and Idiopathic Intracranial Hypertension- A Pathogenetic Link for Aldosterone?
Q J Med 103:699-702, Chitalia, N.,et al, 2010
Clinicopathologic Conference, Thyrotoxic Periodic Paralysis Associated with Graves Disease
NEJM 390:1514-1522, Case 13-2024, 2024
Thyrotoxic Periodic Paralysis
UptoDate Jan, Gutmann, L. & Conwit, R., 2022
Clincopathologic Conference,Graves Disease with Thyrotoxic Periodic Paralysis
NEJM 366:553-560, Case 4-2012, 2012
Clinical and Functional Outcome and Factors Predicting Prognosis in Osmotic Demyelination Syndrome (Central Pontine and/or Extrapontine Myelinolysis) in 25 Patients
JNNP 82:326-331, Kallakatta,R.N.,et al, 2011
Family Paralysis
Lancet 377:352, Sung,C.-C.,et al, 2011
Epilepsy, Ataxia, Sensorineural Deafness, Tubulopathy, and KCNJ10 Mutations
NEJM 360:1960-1970, Bockenhauer,D.,et al, 2009
Woke Up Paralysed--Without Injury or Stroke
Lancet 371:870, Bawaskar,H.S. &Bawaskar,P.H., 2008
Central Pontine Myelinolysis Associated with Hypokalaemia in Anorexia Nervosa
JNNP 74:353-355, Sugimoto,T.,et al, 2003
Primary Aldosteronism
NEJM 339:1828-1834, Ganguly, A., 1998
Thyrotoxic Periodic Paralysis in the US, Report of 7 Cases & Review of the Literature
Medicine 71:109-120, Ober,K.P., 1992
Thyrotoxic Periodic Paralysis
Arch Int Med 149:2597-2600, Kelley,D.E.,et al, 1989
Central Pontine Myelinolysis
Quart J Med 45:373, Tomlinson,B.E.,et al, 1976
The Remote Effects of Cancer on the Nervous System
Proc Roy Soc Med 60:683, Wilkinson,M., 1967